1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About
-
  1. Products
  2. Solutions
  3. Insights+
  4. News & content
  5. About

Shenzhen Meinuo Weichuang Medical Technology

Have updates for this profile?  Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Year established

2017

Location

Shenzhen Guangdong China

Primary Industry

Medical Devices & Equipment

About

Based in Shenzhen, China and established in 2017, Shenzhen Meinuo Weichuang Medical Technology is a healthcare company that provides minimally invasive intervention for cerebral hemorrhage, stroke, brain tumor, cerebral infarction treatment. The company's founder, Wang Disi, worked in companies such as Boston Scientific Corporation, Johnson & Johnson, Terumo Corporation, engaged in the research and development of micro-guide wires, cerebrovascular stents and other neurointerventional products. The company's core team has more than 20 years of experience in the developing interventional medical instruments for cerebrovascular disease. The company mainly provides minimally invasive interventional medical instruments for cerebrovascular diseases, including micro-guide wires, micro-catheters, coils, balloon catheters, cerebrovascular stents, thrombectomy devices, etc.
Current Investors
Shenzhen HTI, Shanghai Creation Investment, Shenzhen Zhiweiying Venture Capital

Request a demo to show more

Primary Industry
Medical Devices & Equipment
Sub Industries
Surgical Devices
Website
www.szpromed.com
Verticals
HealthTech
Company Stage
Angel & Seed
Total Amount Raised
Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.